Global Pulmonary Drug Delivery Systems Market Size study & Forecast and Regional Analysis, 2022-2029

by Product (Dry Powder Inhaler, Metered Dose Inhaler and Nebulizers) by Application (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), and Cystic Fibrosis), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-Commerce)

Published	Pages	Publisher	Report code
May 2023	200	Bizwit Research	ASDR-621569

Published: May 2023 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-621569

AstraZeneca plc
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Novartis AG
Koninklijke Philips N.V.
3M company
Janssen (Johnson & Johnson)
Clement Clarke International
Briggs Healthcare
Aerogen

Pulmonary Drug Delivery Devices - Global Forecast 2024-2030

This report can be of interest as well:

Pulmonary Drug Delivery Devices - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-651940